|
Recent Developments |
|
23-JAN-13
Ajanta Pharma, a specialty focused pharmaceutical formulation company, reported a rise of 75.96% in net profit to Rs 325.7 million for the quarter ended Dec. 31, 2012 as compared to Rs 185.1 million in the same period last year.
26-OCT-12
Ajanta Pharma, an Indian Pharma Company is engaged in manufacturing and marketing of pharmaceutical products based in Mumbai, Maharashtra, reported a rise of 84.64% in net profit to Rs 218.8 millio... More.. |
| Business Profile |
Future Plans |
|
| CEO Talk | | Ajanta Pharma is a typical niche player. The companys managing director Purushottam Agrawal is confident of Ajanta Pharma logging in a growth of at least 15 per cent in its topline and much higher than that in its bottomline. Purushottam Agrawal |
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (12) | 31-Mar-2011 (12) | | Net sales | 5811.50 | 5982.54 | 4571.46 | | Other Income | 106.00 | 12.08 | 16.50 | | Total Income | 5917.50 | 5994.62 | 4587.95 | | Cost of goods sold | 4496.40 | 4723.27 | 3675.97 | | OPBDIT | 1421.10 | 1271.35 | 911.99 | | PAT | 740.30 | 664.91 | 464.45 | | Gross Block | - | - | - | | Equity capital | 118.00 | 117.96 | 117.96 | | EPS (Rs.) | - | 56.79 | 39.67 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 3.53 - 8.66 | 4.34 - 6.90 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 24.0 | 21.2 | 19.9 | | Net margin (% of OI) | 12.5 | 11.1 | 10.1 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
